Prime Medicine, Inc. held its 2026 annual meeting of stockholders on June 5, 2026. Stockholders elected Michael Kelly and David Schenkein, M.D. as Class I Directors and ratified the appointment of PricewaterhouseCoopers LLP as the company's independent registered public accounting firm.
